Kwon So Young
Department of Internal Medicine, National Medical Center, Seoul, Korea.
Taehan Kan Hakhoe Chi. 2003 Sep;9(3):205-11.
BACKGROUND/AIMS: Impaired glucose tolerance and overt diabetes mellitus (DM) frequently occurs in patients with chronic liver disease. Hyperinsulinaemia and peripheral insulin resistance contribute to the development of DM in these patients. The clinical relevance, however, of DM to their clinical course was not determined. We investigated the prevalence of DM in patients with liver cirrhosis and their clinical characteristics and prognosis.
A total of 606 consecutive cirrhotic patients were enrolled for 5 years. We reviewed all laboratory findings, clinical courses, and mortality, retrospectively. The cirrhotic patients were divided into two groups according to the presence of DM, and their clinical characteristics and mortality were compared. DM was diagnosed in accordance with National Diabetes Data Group criteria.
Among the total of 606 cirrhotic patients (M:F, 482:124), 346 (57.1%) had HBV related disease and 60 (10%) had HCV related disease. Forty-five percent of the patients had a history of habitual drinking. DM was observed in 22.4% of the cirrhotic patients. In the diabetic group, the frequency of HCV infection was significantly greater. DM did not affect survival. The DM group, however, appeared to have higher mortality in the patients with Child-Pugh class A cirrhosis during long-term follow up. Only 20.6% of the diabetic patients had normal range blood glucose levels even though most of them received medical therapy. The cases with well controlled blood glucose showed higher survival than poorly controlled cases n the DM group.
Cirrhotic patients have a high prevalence of DM, and more frequently are associated with HCV infection. The strict control of blood glucose and the control of infection could be important in prolonging the survival in compensated cirrhotic patients with DM.
背景/目的:慢性肝病患者常出现糖耐量受损和显性糖尿病(DM)。高胰岛素血症和外周胰岛素抵抗促使这些患者发生DM。然而,DM对其临床病程的临床相关性尚未明确。我们调查了肝硬化患者中DM的患病率及其临床特征和预后。
连续纳入606例肝硬化患者,随访5年。我们回顾性分析了所有实验室检查结果、临床病程和死亡率。根据是否存在DM将肝硬化患者分为两组,比较其临床特征和死亡率。DM根据美国国家糖尿病数据组标准进行诊断。
在总共606例肝硬化患者中(男:女,482:124),346例(57.1%)患有乙型肝炎病毒相关疾病,60例(10%)患有丙型肝炎病毒相关疾病。45%的患者有酗酒史。22.4%的肝硬化患者观察到DM。在糖尿病组中,丙型肝炎病毒感染的频率明显更高。DM不影响生存率。然而,在长期随访中,DM组在Child-Pugh A级肝硬化患者中似乎有更高的死亡率。即使大多数糖尿病患者接受了药物治疗,只有20.6%的患者血糖水平在正常范围内。血糖控制良好的患者在DM组中的生存率高于控制不佳的患者。
肝硬化患者DM患病率高,且更常与丙型肝炎病毒感染相关。严格控制血糖和控制感染对于延长代偿期肝硬化合并DM患者的生存期可能很重要。